Amgen to buy ChemoCentryx for billions in cash

The acquisition adds to Amgen's portfolio of treatments for inflammatory disorders.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 4, 2022 Category: Pharmaceuticals Authors: I-Chun Chen Source Type: news